Norwich Pharmacal
Compulsory disclosure orders against registered agents and financial intermediaries. Piercing the corporate veil to identify Ultimate Beneficial Owners.
Institutional framework for tracing, freezing, and recovering misappropriated assets across offshore jurisdictions. Converting legal claims into executable outcomes.
* Based on enforcement data from cases managed by NWA and affiliated counsel, 2019–2025. Past outcomes are not indicative of future results.
Compulsory disclosure orders against registered agents and financial intermediaries. Piercing the corporate veil to identify Ultimate Beneficial Owners.
Rapid deployment of worldwide freezing orders. Securing liquidity across multiple jurisdictions simultaneously within a 72-hour operational window.
Algorithmic audit of transaction flows. Elimination of arithmetic anomalies and preparation of evidence-grade financial maps for court submission.
Corporate structure mapping, UBO identification, and preliminary asset tracing across target jurisdictions.
Preparation of Norwich Pharmacal applications and Mareva injunction drafts. Coordination with local counsel in each jurisdiction.
Simultaneous filing across jurisdictions. Ex parte hearings and emergency freezing orders within 72-hour window.
Negotiated settlement under pressure of frozen assets, or full enforcement through court-ordered liquidation and distribution.
Model enforcement probability based on jurisdiction, claim size, and documentation readiness. For indicative purposes only.
This tool provides indicative probability estimates based on historical enforcement data. Actual outcomes depend on evidence quality, counterparty behavior, and judicial discretion. This does not constitute legal advice.